readthroughSign in
CompanyFTHNasdaqAustin, TX

Faeth Therapeutics

Faeth Therapeutics develops PIKTOR, an oral combination of PI3K and mTOR inhibitors, in clinical-stage testing for endometrial and breast cancer through multi-pathway inhibition.

SCHEDULE 13GNov 16Latest SEC filing
Nov 13Latest story